440 filings
Page 7 of 22
8-K
azdxe1
9 Mar 21
Departure of Directors or Certain Officers
5:16pm
8-K
kr1xqc ru77vic6yltd
16 Feb 21
Other Events
11:07am
8-K
9czee4ce
21 Jan 21
Entry into a Material Definitive Agreement
5:29pm
424B5
667o53
21 Jan 21
Prospectus supplement for primary offering
5:29pm
424B5
bd1nc21ic7zaxb9 qbu
19 Jan 21
Prospectus supplement for primary offering
4:31pm
8-K
khzguqeg04x
14 Jan 21
AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements
8:53am
424B5
xkuvn8jz3 tn3huuvb
10 Dec 20
Prospectus supplement for primary offering
4:17pm
8-K
xozfrgy9a edu
10 Dec 20
Securities Purchase Agreement
4:16pm
8-K
2zelvzm2ctn
5 Nov 20
AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results
4:16pm
8-K
05a6f9dveg2budx
6 Oct 20
Entry into a Material Definitive Agreement
4:07pm
8-K
x344wyucgz4mumiag
10 Aug 20
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results
4:01pm
424B5
4ee26is
23 Jul 20
Prospectus supplement for primary offering
4:39pm
8-K
rvtsqg mtmjv
23 Jul 20
AcelRx expands DSUVIA commercial opportunity with an established, leading partner to advance surgical care
8:50am
EFFECT
spaaa37u uw
9 Jul 20
Notice of effectiveness
12:15am
CORRESP
f983ajbpsm prim2
7 Jul 20
Correspondence with SEC
12:00am
CORRESP
73nh6zajregxer
6 Jul 20
Correspondence with SEC
12:00am
CORRESP
lkxilm 6u
6 Jul 20
Correspondence with SEC
12:00am
EFFECT
4p9y1ohg3zct
18 Jun 20
Notice of effectiveness
12:15am